Intignus Biotech
PrivateLast Round
Grant
Nov 1, 2025
Total Funding Raised
$1.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Intignus Biotech is a biotechnology company that develops diagnostic devices and point-of-care tests for the early detection of pregnancy-related disorders and maternal health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intignus Biotech Comparables
Compare Intignus Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prantae Solutions | 82% | |
| MOMM Diagnostics | 81% | |
| Kalia Health, Inc. | 77% | |
Intignus Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2025 | ||||
| Accelerator | Mar 15, 2023 | ||||
| VC Round | Dec 20, 2022 | ||||
| Grant | Aug 20, 2020 |
Intignus Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant, VC Round |
| Villgro | Grant |
| Department of Science & Technology | Grant |
| Gates Foundation | Grant |
| Tech4Eva | Accelerator |
| Venture Center | VC Round |
| EPFL Innovation Park | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 274% MoM.
- Nov 1, 2025
$900K grant from the Gates Foundation.
Intignus Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intignus Biotech's valuation, stock price, and market status.